Is Sharda Cropchem overvalued or undervalued?

As of 3 July 2025, Sharda Cropchem's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company appears to be fairly valued at present, with a PE ratio of 26.26, an EV to EBITDA of 12.72, and a PEG ratio of 0.03, which suggests strong growth potential relative to its price.
In comparison to its peers, Sharda Cropchem's PE ratio is lower than that of P I Industries at 38.75 and Bayer CropSci. at 50.39, both of which are considered very expensive. However, it is slightly higher than Dhanuka Agritech's PE of 26.32, which is categorized as expensive. Notably, Sharda Cropchem has outperformed the Sensex over the past year, with a stock return of 79.75% compared to the Sensex's 4.07%, reinforcing its attractiveness in the current market.